首页> 外文期刊>Journal of Korean Neurosurgical Society >Feasibility of Endoscopic Endonasal Approach for Recurrent Pituitary Adenomas after Microscopic Trans-Sphenoidal Approach
【24h】

Feasibility of Endoscopic Endonasal Approach for Recurrent Pituitary Adenomas after Microscopic Trans-Sphenoidal Approach

机译:内镜下经鼻蝶窦入路鼻内镜治疗复发性垂体腺瘤的可行性

获取原文
           

摘要

Objective The surgical approach for recurrent pituitary adenoma after trans-sphenoidal approach (TSA) is challenging. We report the outcomes of the endoscopic TSA for recurrent pituitary adenoma after microscopic TSA. Methods From February 2010 to February 2013, endoscopic TSA was performed for removal of 30 recurrent pituitary adenomas after microscopic TSA. Twenty-seven (90%) patients had a clinically non-functioning pituitary adenoma. Twenty-four (80%) patients suffered from a visual disturbance related to tumor growth. The clinical features and surgical outcomes were retrospectively analyzed for the ophthalmological, endocrinological, and oncological aspects. Results The mean tumor volume was 11.7 cm3, and gross total resection was achieved in 50% of patients. The volumetric analysis based on the postoperative MR showed that the mean extent of resection rates were 90%. Vision was improved in 19 (79%) of 24 patients with visual symptoms, and endocrinological cure was achieved in all of three functioning pituitary adenomas; however, the post-operative follow-up endocrinological examination revealed a new endocrinological deficit in one patient. Two patients required antibiotics management for post-operative meningitis. Conclusion The endoscopic TSA can be an effective treatment option for recurrent pituitary adenoma after microscopic TSA with acceptable outcome.
机译:目的经蝶窦入路(TSA)术后复发性垂体腺瘤的手术方法具有挑战性。我们报告镜下TSA复发性垂体腺瘤的内镜TSA的结果。方法自2010年2月至2013年2月,行内镜下TSA切除30例复发性垂体腺瘤。 27名(90%)患者患有临床上无功能的垂体腺瘤。 24(80%)患者患有与肿瘤生长相关的视觉障碍。回顾性分析眼科,内分泌科和肿瘤科的临床特征和手术结局。结果平均肿瘤体积为11.7 cm 3 ,总切除率达到50%。根据术后MR进行的体积分析显示,平均切除率达到90%。 24例有视觉症状的患者中有19例(79%)的视力得到了改善,并且三个功能正常的垂体腺瘤均获得了内分泌学治愈;然而,术后随访内分泌检查发现一名患者出现了新的内分泌缺陷。两名患者在术后脑膜炎中需要抗生素治疗。结论内镜下TSA可作为镜下TSA术后复发性垂体腺瘤的一种有效治疗方法,疗效满意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号